Canada consults on use of foreign review reports in evaluation of drugs, devices
This article was originally published in Clinica
Executive Summary
Health Canada is seeking feedback on a draft guideline on how it uses review reports from foreign regulatory authorities when evaluating pharmaceutical and medical device applications. The draft document is designed to inform sponsors of the procedures to follow when including foreign review reports in their filings with the government department. It also explains how companies can facilitate Health Canada's use of foreign review reports.
You may also be interested in...
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.